241 related articles for article (PubMed ID: 7926758)
1. The v-abl tyrosine kinase negatively regulates NF-kappa B/Rel factors and blocks kappa gene transcription in pre-B lymphocytes.
Klug CA; Gerety SJ; Shah PC; Chen YY; Rice NR; Rosenberg N; Singh H
Genes Dev; 1994 Mar; 8(6):678-87. PubMed ID: 7926758
[TBL] [Abstract][Full Text] [Related]
2. An active v-abl protein tyrosine kinase blocks immunoglobulin light-chain gene rearrangement.
Chen YY; Wang LC; Huang MS; Rosenberg N
Genes Dev; 1994 Mar; 8(6):688-97. PubMed ID: 7926759
[TBL] [Abstract][Full Text] [Related]
3. The subunit composition of NF-kappa B complexes changes during B-cell development.
Grumont RJ; Gerondakis S
Cell Growth Differ; 1994 Dec; 5(12):1321-31. PubMed ID: 7696180
[TBL] [Abstract][Full Text] [Related]
4. Avian I kappa B alpha is transcriptionally induced by c-Rel and v-Rel with different kinetics.
Schatzle JD; Kralova J; Bose HR
J Virol; 1995 Sep; 69(9):5383-90. PubMed ID: 7636983
[TBL] [Abstract][Full Text] [Related]
5. Function of NF-kappa B/Rel binding sites in the major histocompatibility complex class II invariant chain promoter is dependent on cell-specific binding of different NF-kappa B/Rel subunits.
Brown AM; Linhoff MW; Stein B; Wright KL; Baldwin AS; Basta PV; Ting JP
Mol Cell Biol; 1994 May; 14(5):2926-35. PubMed ID: 8164652
[TBL] [Abstract][Full Text] [Related]
6. The rel-associated pp40 protein prevents DNA binding of Rel and NF-kappa B: relationship with I kappa B beta and regulation by phosphorylation.
Kerr LD; Inoue J; Davis N; Link E; Baeuerle PA; Bose HR; Verma IM
Genes Dev; 1991 Aug; 5(8):1464-76. PubMed ID: 1907941
[TBL] [Abstract][Full Text] [Related]
7. Corepression of RelA and c-rel inhibits immunoglobulin kappa gene transcription and rearrangement in precursor B lymphocytes.
Scherer DC; Brockman JA; Bendall HH; Zhang GM; Ballard DW; Oltz EM
Immunity; 1996 Dec; 5(6):563-74. PubMed ID: 8986716
[TBL] [Abstract][Full Text] [Related]
8. Growth, differentiation, and malignant transformation of pre-B cells mediated by inducible activation of v-Abl oncogene.
Jacobsen EA; Ananieva O; Brown ML; Chang Y
J Immunol; 2006 Jun; 176(11):6831-8. PubMed ID: 16709843
[TBL] [Abstract][Full Text] [Related]
9. A small molecule Abl kinase inhibitor induces differentiation of Abelson virus-transformed pre-B cell lines.
Muljo SA; Schlissel MS
Nat Immunol; 2003 Jan; 4(1):31-7. PubMed ID: 12469118
[TBL] [Abstract][Full Text] [Related]
10. Ras-independent activation of Rel-family transcription factors by UVB and TPA in cultured keratinocytes.
Tobin D; Nilsson M; Toftgård R
Oncogene; 1996 Feb; 12(4):785-93. PubMed ID: 8632900
[TBL] [Abstract][Full Text] [Related]
11. Transcription factor NF-kappa B regulates Ig lambda light chain gene rearrangement.
Bendall HH; Sikes ML; Oltz EM
J Immunol; 2001 Jul; 167(1):264-9. PubMed ID: 11418658
[TBL] [Abstract][Full Text] [Related]
12. IL-7 reconstitutes multiple aspects of v-Abl-mediated signaling.
Banerjee A; Rothman P
J Immunol; 1998 Nov; 161(9):4611-7. PubMed ID: 9794389
[TBL] [Abstract][Full Text] [Related]
13. Differential transcriptional activation in vitro by NF-kappa B/Rel proteins.
Lin R; Gewert D; Hiscott J
J Biol Chem; 1995 Feb; 270(7):3123-31. PubMed ID: 7852394
[TBL] [Abstract][Full Text] [Related]
14. The v-rel oncogene encodes a kappa B enhancer binding protein that inhibits NF-kappa B function.
Ballard DW; Walker WH; Doerre S; Sista P; Molitor JA; Dixon EP; Peffer NJ; Hannink M; Greene WC
Cell; 1990 Nov; 63(4):803-14. PubMed ID: 2225078
[TBL] [Abstract][Full Text] [Related]
15. Interaction of the v-rel protein with an NF-kappa B DNA binding site.
Kabrun N; Hodgson JW; Doemer M; Mak G; Franza BR; Enrietto PJ
Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1783-7. PubMed ID: 1848011
[TBL] [Abstract][Full Text] [Related]
16. Sequential induction of NF-kappa B/Rel family proteins during B-cell terminal differentiation.
Liou HC; Sha WC; Scott ML; Baltimore D
Mol Cell Biol; 1994 Aug; 14(8):5349-59. PubMed ID: 8035813
[TBL] [Abstract][Full Text] [Related]
17. Overproduction of NFKB2 (lyt-10) and c-Rel: a mechanism for HTLV-I Tax-mediated trans-activation via the NF-kappa B signalling pathway.
Lanoix J; Lacoste J; Pepin N; Rice N; Hiscott J
Oncogene; 1994 Mar; 9(3):841-52. PubMed ID: 8108127
[TBL] [Abstract][Full Text] [Related]
18. The v-rel oncogene: insights into the mechanism of transcriptional activation, repression, and transformation.
Walker WH; Stein B; Ganchi PA; Hoffman JA; Kaufman PA; Ballard DW; Hannink M; Greene WC
J Virol; 1992 Aug; 66(8):5018-29. PubMed ID: 1321284
[TBL] [Abstract][Full Text] [Related]
19. NF-kappaB1 can inhibit v-Abl-induced lymphoid transformation by functioning as a negative regulator of cyclin D1 expression.
Nakamura Y; Grumont RJ; Gerondakis S
Mol Cell Biol; 2002 Aug; 22(15):5563-74. PubMed ID: 12101248
[TBL] [Abstract][Full Text] [Related]
20. Constitutive and inducible Rel/NF-kappa B activities in mouse thymus and spleen.
Weih F; Carrasco D; Bravo R
Oncogene; 1994 Nov; 9(11):3289-97. PubMed ID: 7936653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
